DEFINITIVE CONTRACT
Active75F40126C00089
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$645.5K
obligated · signed 2 weeks ago
5-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1AP28: MECHANISTIC EVALUATION OF ORAL PEPTIDE ABSORPTION USING ORGANOID-BASED NAMS TO SUPPORT BIOEQUIVALENCE ASSESSMENT.
Performance timeline
Start
Sep 30, 2026
Current end
Sep 29, 2028
Potential end
Sep 29, 2031
with all options
Loading status
Estimated start: Sep 29, 2030
UNIVERSITY OF FLORIDA
Contract 75F40126C00089
UEI
NNFQH1JAPEP3
Parent Company
UNIVERSITY OF FLORIDA
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$645,503
Base + Exercised Options
$645,503
Total Ceiling Value
$1,667,347
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 09
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.